Episode Details
Back to Episodes
Moderna’s Melanoma Vaccine Shows Promise | Newark News
Description
Moderna’s experimental melanoma vaccine, mRNA-4157, paired with Keytruda, shows major promise in slashing cancer recurrence in advanced-stage patients—offering renewed hope where survival odds were once grim. Built on the same mRNA tech that fought COVID, this breakthrough could redefine long-term cancer care by empowering the immune system to hunt down hidden tumors. Early trial data reveals a significant drop in relapse rates, but FDA approval still lies ahead as researchers closely monitor safety and efficacy over time.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/81bca690f6455560